Technical Analysis for VTL - Vital Therapies, Inc.

Grade Last Price % Change Price Change
grade F 0.2212 6.65% 0.01
VTL closed up 6.65 percent on Monday, March 18, 2019, on approximately normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Down
See historical VTL trend table...

Date Alert Name Type % Chg
Mar 18 20 DMA Resistance Bearish 0.00%
Mar 18 50 DMA Resistance Bearish 0.00%
Mar 18 Inside Day Range Contraction 0.00%
Mar 15 Fell Below 20 DMA Bearish 6.65%
Mar 15 Fell Below 50 DMA Bearish 6.65%
Mar 15 MACD Bearish Signal Line Cross Bearish 6.65%
Mar 15 180 Bearish Setup Bearish Swing Setup 6.65%
Mar 15 BB Squeeze Ended Range Expansion 6.65%
Mar 14 20 DMA Support Bullish -3.83%
Mar 14 50 DMA Support Bullish -3.83%

Older signals for VTL ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel second mitochondrial activator of caspases-mimetics to cause or enable abnormal cells that are resistant to the body's immune system to self-destruct. Its products include Birinapant, a clinical-stage product candidate that is being tested in Phase I and Phase II oncology clinical trials for multiple solid tumors and hematological malignancies, as well as completed a Phase I/II clinical trials for colorectal cancer. The company also evaluates birinapant and other product candidates in pre-clinical studies as antiviral therapeutic agents. It has collaboration with Amgen. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Health Biotechnology Biopharmaceutical Solid Tumors Colorectal Cancer Hematological Malignancies Amgen
Is VTL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.75
52 Week Low 0.15
Average Volume 1,497,611
200-Day Moving Average 2.8283
50-Day Moving Average 0.2221
20-Day Moving Average 0.2257
10-Day Moving Average 0.2244
Average True Range 0.0259
ADX 21.36
+DI 15.9901
-DI 14.6368
Chandelier Exit (Long, 3 ATRs ) 0.2023
Chandelier Exit (Short, 3 ATRs ) 0.2777
Upper Bollinger Band 0.2502
Lower Bollinger Band 0.2012
Percent B (%b) 0.41
BandWidth 21.710235
MACD Line 0.0004
MACD Signal Line 0.0015
MACD Histogram -0.0011
Fundamentals Value
Market Cap 9.34 Million
Num Shares 42.2 Million
EPS -1.35
Price-to-Earnings (P/E) Ratio -0.16
Price-to-Sales 0.00
Price-to-Book 3.02
PEG Ratio -0.27
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.25
Resistance 3 (R3) 0.25 0.24 0.24
Resistance 2 (R2) 0.24 0.23 0.24 0.24
Resistance 1 (R1) 0.23 0.23 0.23 0.23 0.24
Pivot Point 0.22 0.22 0.22 0.22 0.22
Support 1 (S1) 0.21 0.21 0.22 0.21 0.20
Support 2 (S2) 0.21 0.21 0.21 0.20
Support 3 (S3) 0.20 0.21 0.20
Support 4 (S4) 0.20